TVS Emerald’s Atrium @ GreenAcres customer centric 10-85-5scheme

Emerald Haven Realty Ltd (TVS Emerald), the real estate arm of TVS Group Company, announced a unique limited period finance scheme for its newly launched project, TVS Emerald Atrium @GreenAcres, a gated apartment housing project which is a part of 18-acre community development project ‘TVS Emerald Green Acres’.  As a part of the limited period finance 10-85-5 scheme, home buyers will need to pay only 10% on booking and 85% of payment after 2 years, on completion of flooring of the purchased unit, or Jan’24 whichever is earlier. The balance 5% is payable during the possession of the apartment.

This unique limited period finance scheme is launched keeping customer centricity in mind. It gives home buyers payment flexibility as they need not take up a home loan until 2 years, as no demand would be raised. The scheme can be availed till 15th December 2021.

SriramIyer, President & CEO, TVS Emerald, said, “We are delighted with the strong positive response to our newly launched project, TVS Emerald Atrium. Hence, to fast track the project and also offer home buyers a unique value proposition, we have launched a limited period finance 10-85-5 scheme. At TVS Emerald, we understand the pain points of aspiration home buyers, who may have multiple financial obligations. Hence, by opting for this scheme, the customer is not required to take a loan or have a financial burden till 2 years, from the day of booking, thereby ensuring savings on pre-emi of upto Rs. 6 Lakhs.”

He added, “Real estate is a valuable asset and home buyers are willing to take on a lifelong debt for it. For this life time decision, we would like to handhold the customers by offering them a respite wherein they can secure their home without a financial burden. TVS Emerald is the first in Chennai to bring this unique limited period finance scheme to the market and we hope to see many more home buyers benefit from this offering.”

Siva Krishnan, Managing Director –Tamilnadu& Head - Residential Services, India, JLL: “The objective of this unique developer subventions scheme is to ensure a safe passage for home buyers by alleviating the interest burden until the project is significantly built up. This scheme diminishes the risk of a homebuyer and also ensures that the developer delivers in a timely manner. For first time home buyers in Chennai, this is a unique opportunity which will push fence sitter to finalise their purchase decision. This will certainly appeal to the Investors residing in the International destinations as well.”

Spread across 2.5 acres, TVS Emerald Atrium comprises of 4 towers, 8-storied buildings with spacious 2BHK and 3 BHK apartments, ranging in carpet areas from 567 sq. ft. to 845sq.ft. The units are priced at Rs. 49 Lakh onwards. The project hosts a wide array of features and amenities such as 10,800 Sq.ft of central atrium, multi-purpose hall, sit out area, kids play area, badminton court, jogging track, outdoor gym, flower garden, cricket pitch, skating rink, yoga lawn, open amphitheater, feature wall with outdoor theater facility and much more.

Strategically located near Perungalathur, TVS Emerald Atrium is in close proximity with major IT parks, educational institutes and overlooks Vandular forest reserve. Major transportation networks such as Kilambakkam bus terminus, Perungalathus railway station, and Vandalur junction are all location within 5 KM radius. The project is a part of Green Acres which is already a home to 500+ families.

The project has 2 acres of lush green landscaping which comprises of 3 carefully maintained garden and 4 parks, with over 1000+ trees & plants. The project is well planned and equipped with multiple health and wellness amenities. The project is registered with RERA Number: TN/01/Building/0194/2021

 

Comments

Popular posts from this blog

First DPL match was won by US Consulate Staff Team

TATA AIG Strengthens Tamil Nadu Health Insurance Portfolio with New Riders amid Strong Growth

Apollo Cancer Centers now introduces Made in India, CAR T Cell Program